Announcements

Partners Innovation Development Grants Program

September 3, 2015

Process and Procedures – 2013 Program Cycle Background And Purpose Partners HealthCare (PHS) has established the Innovation Development Grants (IDG) program to significantly enhance the commercial outcomes of the innovations of the outstanding scientists, clinicians and staff of PHS and its affiliated institutions. This new PHS-wide initiative is managed by Research Ventures & Licensing (RVL)…

Read More

A Timely Tool: Innovation Discovery Grants

September 1, 2015

A look at two Innovation Discovery Grants programs and a snapshot of how IDG bridges the translational gap. In the race to develop a handheld magnetic resonance device that can measure lung tissue density at the patient bedside, $50,000 might seem like a drop in the bucket. But a $50,000 award from Partners HealthCare’s Innovation…

Read More

Partners Innovation Development Grants Program

August 25, 2015

Process and Procedures – 2013 Program Cycle Background And Purpose Partners HealthCare (PHS) has established the Innovation Development Grants (IDG) program to significantly enhance the commercial outcomes of the innovations of the outstanding scientists, clinicians and staff of PHS and its affiliated institutions. This new PHS-wide initiative is managed by Research Ventures & Licensing (RVL) and…

Read More

Innovation Discovery Grant Update

June 1, 2015

Fighting the Consequences of Obesity Treatment of Liver Disease with a Peptide Fragment Joel Habener, MD MGH, Endocrine Nearly 35% of Americans are obese according to the Center for Disease Control. There are a growing number of therapeutic responses to the potentially devastating consequences of the disease. Among the greatest areas of need is obesity-related…

Read More

Celebrate 2014 Innovation Development Grant Winners

August 1, 2014

Meet our 2014 Innovation Development Grant Winners, with a special focus on Nonsurgical Treatment for Type 2 Diabetes. Nonsurgical Treatment for Type 2 Diabetes Ali Tavakkoli, MD, BWH, Gastrointestinal and General Surgery Type-2 diabetes mellitus (T2DM) affects more than 11% of the US adult population with 35% of US adults having pre-diabetic symptoms- incidence continues…

Read More

Top 20 Technologies: From more than 300 applications – Profiles for three of Partners HealthCare's most promising commercial opportunities

May 1, 2014

Low Field Magnetic Stimulation, Early Urine Biomarkers of Kidney Inflammation, and Portable Magnetic Resonance Lung Density Monitor (MR-LDM) for ICU. Focus on Innovation Development Grant Awards Low Field Magnetic Stimulation Michael Rohan, PhD McLean Hospital, Imaging Center Low Field Magnetic Stimulation is a potential new treatment for depression, and has been observed to produce immediate…

Read More